Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-25 @ 9:50 PM
NCT ID: NCT00663351
Description: None
Frequency Threshold: 0
Time Frame: AEs were collected from enrollment through the end of the study/subject withdrawal whichever came first (up to 10 years). However, after the 5-year study report was presented to the FDA, only subject deaths were collected for AEs. The 6-10 year study requirement from the FDA included revision information, deaths, and subject satisfaction collection only.
Study: NCT00663351
Study Brief: Safety and Effectiveness Study of the Reflection Ceramic Acetabular System
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Reflection Ceramic-Ceramic Hip System (IP) Investigational: Reflection Ceramic-Ceramic Hip System. Ceramic femoral head component and the ceramic acetabular cup insert are composed of Biolox forte aluminum oxide material. Reflection Ceramic-Ceramic Total Hip Replacement: Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem. 18 None 18 308 0 308 View
Reflection FSO V (5 Hole) (Control) Control: Reflection FSO V (5 hole). Acetabular shell with a ultra high molecular weight polyethylene insert and an alumina ceramic femoral head with a Synergy or Spectron EF femoral stem. The Synergy femoral stem are composed of implant grade titanium while the Spectron EF stem is composed of implant grade cobalt chrome. Reflection FSO V Total Hip Replacement: Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem. 7 None 7 148 0 148 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Complications related to an infection SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Proprietary system View
Injuries sustained during a house fire SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications Proprietary system View
Found during a death index search, reason unknown SYSTEMATIC_ASSESSMENT General disorders Proprietary system View
Unknown, not reported by site SYSTEMATIC_ASSESSMENT General disorders Proprietary system View
Overdose SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications Proprietary system View
Emphysema SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders Proprietary system View
Heart failure SYSTEMATIC_ASSESSMENT Cardiac disorders Proprietary system View
Cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) Proprietary system View
Myelodysplastic leukemia SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) Proprietary system View
Cardiac arrest SYSTEMATIC_ASSESSMENT Cardiac disorders Proprietary system View
Other Events(If Any):